000			02054 a2200613 4500
005			20250517132243.0
264		0	_c20170718
008			201707s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0168544 _2doi
040			_aNLM _beng _cNLM
100	1		_aSarrazin, Christoph
245	0	0	_aHCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment. _h[electronic resource]
260			_bPloS one _c2016
300			_ae0168544 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
650	0	4	_aAcrylates _xtherapeutic use
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAminoisobutyric Acids
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aBenzimidazoles _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGenotype
650	0	4	_aHepacivirus _xgenetics
650	0	4	_aHepatitis C, Chronic _xcomplications
650	0	4	_aHumans
650	0	4	_aLeucine _xanalogs & derivatives
650	0	4	_aLiver Cirrhosis _xcomplications
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOligopeptides _xtherapeutic use
650	0	4	_aPrognosis
650	0	4	_aProline _xanalogs & derivatives
650	0	4	_aQuinolines
650	0	4	_aRNA, Viral _xgenetics
650	0	4	_aRibavirin _xtherapeutic use
650	0	4	_aThiazoles _xtherapeutic use
650	0	4	_aViral Load
650	0	4	_aYoung Adult
700	1		_aManns, Michael
700	1		_aCalleja, Jose Luis
700	1		_aGarcia-Samaniego, Javier
700	1		_aForns, Xavier
700	1		_aKaste, Renee
700	1		_aBai, Xiaofei
700	1		_aWu, Jing
700	1		_aStern, Jerry O
773	0		_tPloS one _gvol. 11 _gno. 12 _gp. e0168544
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0168544 _zAvailable from publisher's website
999			_c26737552 _d26737552